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Abstract
Background: Lower respiratory tract infections (LRTI) are responsible for a considerable number of deaths among
children, particularly in developing countries. In Egypt and the Middle East region, there is a lack of data regarding
the viral causes of LRTI. In this study, we aimed to identify the relative prevalence of various respiratory viruses that
contribute to LRTIs in young children. Although, nucleic acid-based methods have gained importance as a sensitive
tool to determine the viral infections, their use is limited because of their prohibitive cost in low-income countries.
Therefore, we applied three different laboratory methods, and presented the different virus prevalence patterns
detected by each method.
Methods: We collected nasopharyngeal aspirate samples, demographic data and, clinical data from 450 children
under five years of age who presented with LRTI at Abou El Reesh hospital in Cairo during a one-year period. To
identify the viral causes of the LRTI we used direct fluorescence assay, real-time reverse-transcriptase polymerase
chain reaction (rt-RT-PCR), and shell vial culture. We tested for eight major respiratory viruses.
Results: Two hundred sixty-nine patients (59.9%) had a viral infection, among which 10.8% had a co-infection with
two or more viruses. By all three methods, respiratory syncytial virus (RSV) was the most predominant, and
parainfluenza virus type 2 (HPIV-2), influenza B virus (FLUBV) were the least predominant. Other viral prevalence
patterns differed according to the detection method used. The distribution of various viruses among different age
groups and seasonal distribution of the viruses were also determined.
Conclusions: RSV and human adenovirus were the most common respiratory viruses detected by rt-RT-PCR.
Co-infections were found to be frequent among children and the vast majority of co-infections were detected by
nucleic acid-based detection assays.
Keywords: Egypt, Direct fluorescence assay, Lower respiratory tract infections, Pediatric, Polymerase chain reaction,
Respiratory viruses, Shell vial culture
Background
Acute respiratory infections (ARI) can be very severe in
young children, and ARI account for one-fifth of all
deaths in children less than five years of age. Of those
mortalities, 70% occur in Africa and Southeast Asia [1].
Approximately one-third of children will develop lower
respiratory tract infections (LRTI) within the first year
of life [2]. Premature infants and/or those with com-
promised immune systems are particularly susceptible
to developing respiratory syncytial virus (RSV) related
LRTI [3].
Pediatric patients with either upper or lower respira-
tory tract infections are typically treated symptomatically
as outpatients. Diagnostic specimens are generally only
obtained and tested in hospital settings, and even then
treatment is usually initiated without etiologic determin-
ation. In the US, about 1-2% of infants presenting with
LRTI require hospitalization [4].* Correspondence: caroline.fayez.eg@med.navy.mil
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In studies conducted in Europe, a pathogen was identi-
fied in 60-85% of LRTI cases [5-7]. Viral etiology
accounted for 39-62% of the cases while S. pneumoniae
accounted for 37% of the cases. The viruses identified
included RSV in 24-29% of the cases, rhinoviruses in
24%, human parainfluenza viruses (HPIV) in 10%, and
human adenoviruses (HAdV) in 7%, influenzaviruses A
and B (FLUAV and FLUBV) in 4-5% of the cases [5-8].
The etiology of viral pneumonia in Egypt was
described in a study of patients under five years of age
published in 1967–68. HAdV, RSV, human parainfluenza
viruses 1 through 3 (HPIV-1, HPIV-2, and HPIV-3), and
FLUAV infections were diagnosed by seroconversion [9].
In an effort to improve the treatment of patients with re-
spiratory illness, Egypt embarked on formalized phys-
ician training in case management of ARI in the 1980s
and 1990s [10,11]. Recently, the burden of atypical
pathogens as Chlamydia and Mycoplasma spp. causing
LRTI in children was studied in Egypt [12]. HAdV was
also detected using serological methods in 30% of the
patients [13]. The clinical presentation of RSV and non-
RSV infected children were recently compared in Egypt
[14]. Moreover, the burden of a number of respiratory
viruses in Middle East countries has been described in
several studies [15-21]. Nevertheless, there is a dearth of
literature and information regarding the viral etiology of
respiratory tract infections in pediatric patients in Egypt
and Middle East countries.
Respiratory viral diagnostics rely principally on four
techniques: virus isolation in cell cultures, antibody de-
tection (serology), antigen detection, and nucleic acid-
based molecular methods [22,23]. For rapid results in a
clinical setting, virus isolation is not effective because
results can take up to 14 days, which is not timely for
treatment decisions. Antigen detection assays such as
the direct fluorescence assays (DFA) are more com-
monly used in clinical settings, because same-day results
can be obtained. Nucleic acid-based detection methods
such as polymerase chain reaction (PCR) are the gold
standard in research laboratories because they are very
sensitive; however, these are cost prohibitive in many
clinical settings, particularly in newly industrialized and
developing nations.
In this study, we sought to determine the predominant
viral etiologies of LRTI in pediatric patients and to
examine the performance of different laboratory diag-
nostic methods for the detection of these viruses.
Methods
Study Design
A prospective study enrolled pediatric patients under
five years of age presenting to the emergency room or
the outpatient clinic at Abou El Reesh Hospital in Cairo
over a one-year period. Children presenting with any
combination of cough, difficulty breathing, fever, chest
indrawing, and rapid breathing (> 50 respirations/minute
for children under one year of age and > 40 respirations/
minute for children from one to five years of age) were
enrolled. Chest X-ray results (if available) were obtained
at the time of admission. The episode was designated as
a radiologically confirmed pneumonia case if an area of
consolidation and/or pleural effusion was determined on
the chest X-ray. Demographic data and clinical symp-
toms of the enrolled patients were recorded. Signed
informed consent was obtained from the parent or
guardian. Patients were excluded if they were over five
years of age, unable or unwilling to participate, or if they
were already enrolled in the study for the same episode
of illness.
Sample collection
Nasopharyngeal aspirates (NPA) from participants were
obtained using a mucus trap (ARGYLE™ DeLee, Kendall,
MA, USA). The collected volume ranged from 0.5 to
2 ml. Viral transport media (Hank’s Balanced Salt Solu-
tion (Gibco, Invitrogen, NY, USA) with 2.5% w/v Bovine
Serum Albumin (Sigma, MO, USA), 2% Penicillin/
Streptomycin (Gibco, Invitrogen, NY, USA), and 2.5%
HEPES Buffer (Gibco, Invitrogen, NY, USA)) was added
to each aspirate. The NPAs were immediately placed at
4°C and transferred to the U.S. Naval Medical Research
Unit #3 (NAMRU-3) Cairo, Egypt within 48 hours for
viral testing. Upon receipt, the samples were divided into
two aliquots. One aliquot was used for direct viral test-
ing by the DFA and the second was kept at −70°C for
nucleic acid extraction and virus isolation.
Viral Testing
RSV, HAdV, HPIV-1, HPIV-2, HPIV-3, FLUAV and
FLUBV were tested using DFA, real-time reverse-
transcriptase polymerase chain reaction (rt-RT-PCR),
and shell vial culture (SVC) procedures. Human metap-
neumovirus (hMPV) was assessed with rt-RT-PCR only.
DFA
Aliquots were centrifuged at 700xg for 10 minutes at
4°C. The cell pellets containing mucus were mixed vigor-
ously for 30 seconds and washed with 1 ml phosphate
buffered saline (PBS) 3–5 times to remove mucus. At the
final wash the supernatant was discarded. The remaining
cell pellet was resuspended in 150-250 μl PBS and the
sample was examined to determine if the minimum con-
centration of cells were present (100 cells at 20x magnifi-
cation). The cell suspension was used to prepare an
eight-well slide and the wells were stained using Res-
piratory Panel 1 Direct Immunofluorescence Assay kit
(LIGHT DIAGNOSTICSTM Millipore, CA, USA) accord-
ing to manufacturer’s instructions.
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rt -RT-PCR
The automated MagMAX Express 96 (Applied Biosys-
tems, CA, USA) was used to extract 200 μl of the second
stored aliquot according to the Total Nucleic Acid Isola-
tion Kit protocol from Ambion (Ambion, Inc. NY, USA).
Each sample was eluted in 80 μl. Rt-RT-PCR was per-
formed according to the Centres for Disease Control
and Prevention (CDC) protocols and using reagents pro-
vided by the CDC. A sample was considered positive
when the cycle threshold was below 36.
SVC
R-Mix ReadyCells Vials with coverslip (Diagnostic
Hybrids Inc. OH, USA) were used for rapid virus isola-
tion according to the manufacturer’s instructions.
Statistical analysis
To determine the prevalence of viral etiologies at differ-
ent age strata, patients were divided into four age
groups, and the prevalence of each virus was determined
for each group. Fisher's exact tests with stepdown Bon-
ferroni correction for multiple comparisons were per-
formed with SAS Version 9.2 (SAS Institute Inc., NC,
USA); p < 0.05 was considered significant.
Results
Patients' characteristics
To assess the viral etiologies of LRTI in young children,
we enrolled a total of 450 patients according to the pre-
viously mentioned case definition during the period
from November 2006 to December 2007. Clinical and
demographic data were available for 448 (99%) of the
patients. Almost all cases (90%) were residents of the
greater Cairo area. The mean age of children was
1.1 years and the median age was 8 months. Forty per-
cent of the cases were aged six months or younger. Male
children constituted 57.4%. Of the 450 patients, 117
(26%) needed supplementary oxygen, 64 (14.2%) were
hospitalized, 4 (0.9%) were admitted to the intensive care
unit, among whom 2 (0.4%) died (Table 1).
Prevalence of respiratory viruses among patients
At least one respiratory virus was detected in 269
(59.9%) of cases, and a total of 324 viruses were
detected. Co-infection with multiple viruses occurred in
10.8% of the participants. Table 2 shows the viral eti-
ology of the enrolled patients. All but three co-infections
were detected by rt-RT-PCR. The seasonal distribution
of the viruses during the study year is shown in Figure 1.
HAdV could be detected throughout the year, and
peaked in April and August, while RSV could only be
detected from November through mid February.
In this study, we used three different techniques
to diagnose viral infections. The trend of the most
predominant and the least predominant viral causes
were maintained. However, the relative percentage of
cases detected with each method varied. Rt-RT-PCR was
the most sensitive for almost all tested viruses. Using rt-
RT-PCR as the gold standard, depending on the virus
examined the sensitivity of DFA varied from 0% to 77.8%
and the specificity varied from 99% to 100% (Additional
file 1). Using rt-RT-PCR as the gold standard, depending
on the virus examined the sensitivity of SVC varied from
0% to 60% and the specificity varied from 99 to 100%
(Additional file 2). The DFA results implicated that
HAdV and the HPIV-3 were equally prevalent among
patients, and were the second most prevalent viruses fol-
lowing the RSV. On the other hand, the SVC results
showed that HAdV, HPIV-3 and HPIV-1 were equally
prevalent and followed the RSV in prevalence (Figure 2).
The combined results of the three methods showed
that RSV was found in 23.8% of the cases (Table 3), with
34.8% of children under six months old positive for RSV.
Compared to other tested viruses RSV was significantly
more common in this age group (p < 0.0001). HAdV had
an overall prevalence of 18.4% among patients. HAdV
was the most frequently detected virus among children
aged from 7–12 months, significantly higher than FLUBV,
HPIV-1, or HPIV-2 (p < 0.003). Among the same age
group, RSV was the second most prevalent virus, and was
significantly more prevalent than FLUBV, HPIV-1, or
HPIV-2 (p < 0.02). HAdV was also the most frequently
detected virus among children aged 13–24 months old,
Table 1 Demographic and clinical characteristics of
pediatric patients with LRTI during 2007
Patients' characteristics n (%)









Greater Cairo 406 (90)
Lower Egypt 12 (2.7)
Upper Egypt 22 (4.9)
Clinical symptoms (n = 447)1
Cough 438 (98)
Difficulty in breathing 415 (93)
Chest indrawing 339 (76)
Fever 325 (73)
1 the number of cases who provided answers to the questionnaire.
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and was significantly higher than FLUAV, FLUBV, HPIV-
1, HPIV-2, or hMPV (p < 0.04). Among the oldest age
group (25–60 months), HAdV had the highest prevalence,
and was significantly higher than FLUAV, FLUBV, or
hMPV (p < 0.03). Among this age group, RSV was the
second most prevalent virus, and was significantly higher
than FLUAV or FLUBV (p < 0.03).
Of the 450 patients tested, 75% were sampled within
the first week post-onset of symptoms. Half of these
were collected in the first three days post-onset. One
quarter of the patients were sampled from day 8 to
> 4 weeks post-onset of symptoms. Compared to DFA
or SVC, rt-RT-PCR demonstrated superior sensitivity for
viral detection at all time points after symptom onset
(Data not shown).
Discussion
Determining the etiology of LRTIs in children has long
been of interest to the research and clinical community.
Viruses have been shown to be the causative agent
in 36-85% of LRTIs among children [5-7,21,24]. Differ-
ent sampling techniques, detection methodologies,
and geographical areas can greatly influence the
observed burden from each virus. In our study, we tested
for eight of the most common respiratory viruses using
three popularly used methodologies and identified at
least one virus in 59.9% of the cases. Consistent with
results of studies conducted in other countries, among
the 324 viruses detected, RSV was the most common
viral agent among children under five years of age, fol-
lowed by HAdV; FLUBV was the least common virus
detected [2,21,25-27].
DFA has been widely used in the clinical settings be-
cause of the high specificity and rapid results. However,
DFA is not as sensitive as nucleic acid-based molecular
methods. In our study, 22% of samples had a detectable
virus by DFA, which is slightly lower than the 32-63%
reported by other studies using an indirect immuno-
fluorescence assay [28,29]. Our DFA results indicate that
RSV accounted for 17.6% of all the LRTI, followed by
HPIV-3 (1.8%) and HAdV (1.6%); these percentages are
on the low end of the ranges reported by other studies
using similar methodologies [21,28,29]. FLUAV contribu-
ted to 0.5% of viruses detected using DFA, while other
studies reported rates of 2-15% [28,29]. This difference
may represent a true difference in FLUAV burden be-
tween the two studies, particularly because the Tang
et al. and Zhang et al. studies tested children up to
16 years of age. Other possibilities exist, such as the dif-
ferent sensitivities of the slightly different methods used
or year-to-year variations in FLUAV prevalence. Our
findings for HPIV-1 (0.9%), HPIV-2 (0%) and FLUBV
(0%) using DFA were similar to another published study
that reported rates of HPIV-1 (0.6%), HPIV-2 (0.1%) and
FLUBV (0.2%) [28]. In contrast, other studies have
reported higher detection levels of these three viruses,
which could be due to differences in study populations,
sensitivity of the assays, or sample quality. Finally, al-
though the detection of co-infections using the immuno-
fluorescence assay was reported [28,29], we did not
identify any co-infections with DFA, even though we
detected co-infections using other methods. The SVC
system is a recently developed method using R-Mix™
cells, and decreases viral detection times from 12–
Table 2 Viral etiology of patients











HAdV + hMPV 6
HAdV + HPIV-1 1
HAdV + HPIV-2 2
HAdV + HPIV-3 6
HAdV + FLUAV 1
HAdV + RSV 3
FLUAV + HPIV-2 1
FLUAV + HPIV-3 1
FLUAV + RSV 6
FLUBV + HPIV-3 1
hMPV + HPIV-2 1
hMPV + RSV 1
HPIV-1 + HPIV-2 2
HPIV-1 + HPIV-3 3
HPIV-2 + RSV 5
HPIV-3 + RSV 3
More than 2 viral agents
HAdV + FLUBV + HPIV-3 1
HAdV + hMPV + RSV 1
HAdV + HPIV-1 + HPIV-3 1
HAdV + HPIV-3 + RSV 1
HPIV-2 + HPIV-3 + RSV 1
HAdV + HPIV-2 + HPIV-3 + RSV 1
NEGATIVES 172
TOTAL PATIENTS 450
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14 days for conventional methods to 24–72 hours [30].
Moreover, some studies demonstrated that the R-Mix™
SVC method is more sensitive for respiratory viruses de-
tection than conventional cell culture, and does not sig-
nificantly increase laboratory virus isolation costs
[31,32]. Our study identified a virus in 26.7% of the
patients using the R-Mix™ SVC, which is comparable to
a Malaysian study reporting 22% positive by conven-
tional isolation in MDCK, Vero, and Hep-2 cell lines
[33]. Using the SVC method, RSV was the most com-
mon virus isolated, followed by HPIV-1 and HPIV-3,
which is consistent with results using traditional virus
isolation methods [33]. LaSala et al. reported that the R-
Mix™ system had a low sensitivity for HAdV detection
[30] which our results also confirm (Additional files 2).
The higher FLUAV prevalence reported by the Malay-
sian study could be due to the different age group en-
rolled in the Malaysian study (0–24 months). In both
studies, FLUBV was the least common virus among
young children with LRTI. Using the SVC system, RSV
was successfully isolated. However, better results might
have been obtained if the samples were directly inocu-
lated into vials without freezing and thawing, because
this is particularly detrimental to the RSV infectivity.
The rt-RT-PCR method detected a viral agent in 59.3%
of the participants, which is similar to other studies (35-
66%) that used nucleic acid-based techniques [26,34,35].
RSV is the most predominant virus among LRTI
patients using rt-RT-PCR, DFA, and SVC, in agreement
with studies worldwide [25,26,36]. Our study demon-
strated that HAdV, detected in 18.5%, is the second most
common causative viral agent for LRTI. Similar observa-
tions were reported by other studies [26].
Although for many years virus isolation was the gold
standard method to diagnose respiratory virus infections,
molecular methods have demonstrated superior viral de-
tection sensitivity. Virus isolation remains an important
aspect of virus detection because it is the only means
of obtaining a viable infectious virus for further char-
acterization. Isolation alone greatly underestimates the
prevalence of respiratory viruses, based on results from
nucleic acid detection methods used in this study. This
is particularly true for viruses that do not grow well in
culture or are highly susceptible to freeze/thaw cycles.
For instance, in this study, the rate of prevalence for
HAdV is greatly underestimated by DFA (1.6%) and
SVC (3.6%) compared to rt-RT-PCR (18.6%). Studies
that used a different laboratory technique for each virus
Figure 1 Monthly distribution of respiratory viruses causing LRTI in children during the study period. The percentages were calculated
by dividing the number of samples positive for each virus by the number of samples collected during each month.
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had high detectable rates for viruses identified by PCR
compared to viruses identified using DFA or virus isola-
tion [21]. This difference should be considered when
designing surveillance studies to estimate the burden of
viral etiologies of respiratory diseases.
The greater the number of days between symptom
onset and sample collection, the more difficult it is to
detect a causative agent. Most respiratory viruses are
present in high titers in the respiratory tract in the first
three days after symptom onset, whereas viral nucleic
acid may remain for longer periods. Therefore, isolation-
based methods such as SVC loose sensitivity after the
first three days post-onset of symptoms, and DFA is
similarly affected when viral titers decrease over the
course of infection. In contrast to SVC and DFA, rt-RT-
PCR remains a sensitive method for virus detection even
after two weeks after symptom onset. The high sensitiv-
ity of rt-RT-PCR means it can detect a very low titer
virus, or viral nucleic acid long after the virus has disap-
peared, making it difficult to determine if the detected
virus is the primary contributor to disease. Thus, nucleic
acid detection results must be interpreted with caution,
particularly if the sample was taken late after symptom
onset [37].
With the development of the PCR scientists were able
to detect co-infections at a level not previously possible
[26,34,38]. One caveat of this approach is that it is un-
clear which virus(es) are contributing to disease. By
virtue of the nucleic acid-based assay, there is no com-
petition for detection of the various etiologies (unlike
SVC) and the amplification step enables detection at
lower quantities (unlike DFA). Consequently, PCR is the
most useful method to detect co-infections representing
near-past and current infections, because of its ability to
detect very low viral titers and/or lingering nucleic acid
still present later in the infection course. Several com-
mon or newly identified respiratory viruses were not
assessed in this study, such as picornaviruses, corona-
viruses, bocaviruses and newly discovered polyoma-
viruses, so their contribution to respiratory disease
etiology and rates of co-infection in Egypt remain
unknown.
Table 3 Distribution of individual respiratory pathogens (n = 324) detected in 450 children
Age in months1 RSV n(%) HAdV n(%) HPIV-1 n(%) HPIV-2 n(%) HPIV-3 n(%) hMPV n(%) FLUAV n(%) FLUBV n(%)
0-6, (n = 184) 64 (34.8) 18 (9.7) 12 (6.5) 2 (1.08) 11 (5.9) 11 (5.9) 2 (1.08) 0 (0)
7-12, (n = 92) 18 (19.5) 21 (22.8) 5 (3.2) 2 (2.17) 10 (10.8) 10 (10.8) 7 (7.6) 1 (1.08)
13-24, (n = 102) 12 (11.7) 27 (26.4) 7 (6.8) 3 (2.9) 13 (12.7) 5 (4.9) 7 (6.8) 3 (2.9)
25-60 , (n = 70) 13 (18.5) 17 (24.2) 6 (8.5) 7 (10) 6 (8.5) 3 (4.2) 0 (0) 1 (1.4)
Total positive (n = 450)2 107 (23.8) 83 (18.4) 30 (6.6) 14 (3.1) 40 (8.9) 29 (6.4) 16 (3.5) 5 (1.1)
1 Cases were not added up to n due to missing answers.
2 Percentages do not add up due to viral co-infections.
Figure 2 The percentage positive of each virus detected by each laboratory method showing the relative prevalence of each virus if a
particular method was used. The percentages were calculated by dividing the number of samples positive for each virus by the total number
of samples tested by each of the three methods.
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Conclusions
We identified a viral etiology in 59.9% of cases of LRTI in
children aged five years and under in Egypt. RSV and
HAdV were the most commonly detected viruses in
this study.
Additional files
Additional file 1: Sensitivity and specificity of DFA vs PCR.
Additional file 2: Sensitivity and specificity of SVC vs PCR.
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